Federal Register / Vol. 62, No. 27 / Monday, February 10, 1997 / Notices 5993

Dated: February 4, 1997.

LaVerne Y. Stringfield,

NIH Committee Management Officer.

[FR Doc. 97–3207 Filed 2–7–97; 8:45 am]

BILLING CODE 4140–01–M

National Cancer Institute; Notice of

Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following meeting

of the National Cancer Institute Initial

Review Group:

Agenda/Purpose: To review and evaluate

grant applications.

Committee Name: Subcommittee E—

Prevention and Control Subcommittee.

Date: April 7–8, 1997.

Time: 9 a.m.

Place: Holiday Inn Georgetown, 2101

Wisconsin Avenue, NW, Washington, DC

20007.

Contact Person: Sally A. Mulhern, Ph.D.,

Scientific Review Administrator, National

Cancer Institute, NIH, 6130 Executive Blvd.

Room 643G, Bethesda, Md 20892, Telephone:

301–496–7413.

The meeting will be closed in accordance

with the provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program Numbers: 93.393, Cancer Cause and

Prevention Research; 93.394, Cancer

Detection and Diagnosis Research; 93.395,

Cancer Treatment Research; 93.396, Cancer

Biology Research; 93.397, Cancer Centers

Support; 93.398, Cancer Research Manpower;

93.399, Cancer Control)

Dated: February 4, 1997.

LaVerne Y. Stringfield,

NIH Committee Management Officer.

[FR Doc. 97–3208 Filed 2–7–97; 8:45 am]

BILLING CODE 4140–01–M

National Cancer Institute; Notice of

Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following meeting

of the National Cancer Institute Initial

Review Group:

Agenda/Purpose: To review and evaluate

grant applications.

Committee Name: Subcommittee G—

Education Subcommittee.

Date: March 4–5, 1997.

Time: 8 a.m.

Place: Holiday Inn Georgetown, 2101

Wisconsin Avenue, NW, Washington, DC

20007.

Contact Person: John W. Abrell, Ph.D.,

Scientific Review Administrator, National

Cancer Institute, NIH, 6130 Executive Blvd.,

Room 635B, Bethesda, Md 20892, Telephone:

301–496–9767.

The meeting will be closed in accordance

with the provision set forth in sections

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program Numbers: 93.393, Cancer Cause and

Prevention Research; 93.394, Cancer

Detection and Diagnosis Research; 93.395,

Cancer Treatment Research; 93.396, Cancer

Biology Research; 93.397, Cancer Centers

Support; 93.398, Cancer Research Manpower;

93.399, Cancer Control)

Dated: February 4, 1997.

LaVerne Y. Stringfield,

NIH Committee Management Officer.

[FR Doc. 97–3211 Filed 2–7–97; 8:45 am]

BILLING CODE 4140–01–M

National Cancer Institute; Notice of

Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Cancer Institute Special

Emphasis Panel (SEP) meetings:

Name of SEP: Iatorgenic Causes of Cancer.

Date: February 18–20, 1997.

Time: 7:00 pm—February 18; 8:00 am—

February 19 and 20.

Place: Sheraton Grande Hotel, 333

Figueroa Street, Los Angeles, California

90071.

Contact Person: Ray Bramhall, Ph.D.,

Scientific Review Administrator, National

Cancer Institute, NIH, Executive Plaza North,

Room 636, 6130 Executive Boulevard, MSC

7405, Bethesda, MD 20892–7405, Telephone:

301/496–3428.

Purpose/Agenda To Evaluate and review

grant applications.

This notice is being published less than 15

days prior to the meeting due to the urgent

need to meet timing limitations imposed by

the review and funding cycle.

Name of SEP: NCI Cancer Education Grant

Program.

Date: March 5, 1997.

Time: 5:00 pm

Place: Holiday Inn Georgetown, 2101

Wisconsin Avenue, NW, Washington, DC

20007.

Contact Person: John L. Meyer, Ph.D.,

Scientific Review Administrator, National

Cancer Institute, NIH, Executive Plaza North,

Room 611C, 6130 Executive Boulevard, MSC

7405, Bethesda, MD 20892–7405, Telephone:

301/496–7721.

Purpose/Agenda To evaluate and review

grant applications.

These meetings will be closed in

accordance with the provisions set forth in

sections 552b(c)(4) and 552b(c)(6), Title 5,

U.S.C. Applications and the discussions

could reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with the

applications, the disclosure of which would

constitute a clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Program Numbers: 93.393, Cancer Cause and

Prevention Research; 93.394, Cancer

Detection and Diagnosis Research; 93.395,

Cancer Treatment Research; 93.396, Cancer

Biology Research; 93.397, Cancer Centers

Support, 93.398, Cancer Research Manpower;

93.399, Cancer Control)

Dated: February 4, 1997.

LaVerne Y. Stringfield,

NIH Committee Management Officer.

[FR Doc. 97–3213 Filed 2–7–97; 8:45 am]

BILLING CODE 4140–01–M

National Institute of Allergy and

Infectious Diseases; Notice of Closed

Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Allergy and

Infectious Diseases Special Emphasis

Panel (SEP) meeting:

Name of SEP: Accute Infection and Early

Disease Research.

Date: March 4–5, 1997.

Time: 8:30 a.m.

Place: Bethesda Ramada Hotel,

Ambassador 1 Conference Room, 8400

Wisconsin Avenue, Bethesda, MD 20814,

(301) 654–1000.

Contact Person: Dr. Stanley C. Oaks,

Scientific Review Adm., 6003 Executive

Boulevard, Solar Bldg., Room 4C10,

Bethesda, MD 20892, (301) 496–7042.

Purpose/Agenda: To evaluate grant

applications.

The meeting will be closed in accordance

with the provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.855, Immunology, Allergic

and Immunologic Diseases Research; 93.856,

Microbiology and Infectious Diseases

Research, National Institutes of Health)